(Press-News.org) ANN ARBOR—The discovery of a gene mutation that causes a rare premature aging disease could lead to the development of drugs that block the rapid, unstoppable cell division that makes cancer so deadly.
Scientists at the University of Michigan and the U-M Health System recently discovered a protein mutation that causes the devastating disease dyskeratosis congenita, in which precious hematopoietic stem cells can't regenerate and make new blood. People with DC age prematurely and are prone to cancer and bone marrow failure.
But the study findings reach far beyond the roughly one in 1 million known DC patients, and could ultimately lead to developing new drugs that prevent cancer from spreading, said Jayakrishnan Nandakumar, assistant professor in the U-M Department of Molecular, Cellular, and Developmental Biology.
The DC-causing mutation occurs in a protein called TPP1. The mutation inhibits TPP1's ability to bind the enzyme telomerase to the ends of chromosomes, which ultimately results in reduced hematopoietic stem cell division. While telomerase is underproduced in DC patients, the opposite is true for cells in cancer patients.
"Telomerase overproduction in cancer cells helps them divide uncontrollably, which is a hallmark of all cancers," Nandakumar said. "Inhibiting telomerase will be an effective way to kill cancer cells."
The findings could lead to the development of gene therapies to repair the mutation and start cell division in DC patients, or drugs to inhibit telomerase and cell division in cancer patients. Both would amount to huge treatment breakthroughs for DC and cancer patients, Nandakumar said.
Nandakumar said that a major step moving forward is to culture DC patient-derived cells and try to repair the TPP1 mutation to see if telomerase function can be restored. Ultimately, the U-M scientist hopes that fixing the TPP1 mutation repairs telomerase function and fuels cell division in the stem cells of DC patients.
"It's conceivable that with the recent advancement in human genome-editing technology, we could, in the not-so-distant future, repair the mutation in hematopoietic stem cells in the bone marrow of DC patients," Nandakumar said.
The findings also reinforce how one tiny change in an amino acid chain can cause devastating health consequences.
"It was surprising to us that just deleting one single amino acid in a protein chain that is 544 amino acids long can result in such a severe disease," Nandakumar said.
INFORMATION:
First author Hande Kocak conducted the research in Nandakumar's lab in the Department of Molecular, Cellular, and Developmental Biology. She is in the Department of Human Genetics at the U-M Medical School. Co-author Dr. Catherine Keegan is Kocak's mentor and has appointments in the departments of Human Genetics and Pediatrics.
The study, "Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1," appears in the journal Genes and Development.
Study: http://bit.ly/1pE6cqJ
Jayakrishnan Nandakumar: http://bit.ly/1nFwdMf
Molecular, Cellular, and Developmental Biology: http://www.lsa.umich.edu/mcdb
Disease decoded: Gene mutation may lead to development of new cancer drugs
2014-09-30
ELSE PRESS RELEASES FROM THIS DATE:
New guidelines for treatment of hypothyroidism endorse current therapy
2014-09-30
WASHINGTON (Sept. 30, 2014) — Levothyroxine is considered the gold standard therapy for an underactive thyroid gland (hypothyroidism), and a new review of therapies for the condition — including combining levothyroxine with another agent — has not altered that assessment, say a team of investigators.
1Their analysis, published as a set of guidelines in the journal Thyroid, finds insufficient consistent data exist to recommend a change in use of levothyroxine — whether generic, or sold under various trade names, such as Synthroid® — as the only drug needed to treat hypothyroidism.
"Levothyroxine ...
A new dimension for integrated circuits: 3-D nanomagnetic logic
2014-09-30
This news release is available in German.
Electrical engineers at the Technische Universität München (TUM) have demonstrated a new kind of building block for digital integrated circuits. Their experiments show that future computer chips could be based on three-dimensional arrangements of nanometer-scale magnets instead of transistors. As the main enabling technology of the semiconductor industry – CMOS fabrication of silicon chips – approaches fundamental limits, the TUM researchers and collaborators at the University of Notre Dame are exploring "magnetic computing" ...
Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs
2014-09-30
PHILADELPHIA – Federally Qualified Health Centers (FQHCs) granted new patient appointments to Medicaid beneficiaries and uninsured patients at higher rates than other primary care practices (non-FQHCs), in addition to charging less for visits, according to results of a new 10-state University of Pennsylvania study published this month in Medical Care.
Using data from a previous "secret shopper" study conducted in 2012 and 2013, the investigators found that FQHCs — community health clinics that receive federal funding to provide primary care access to underserved populations ...
UCI study uncovers important process for immune system development
2014-09-30
Irvine, Calif., Sept. 30, 2014 — Research by UC Irvine immunologists reveals new information about how our immune system functions, shedding light on a vital process that determines how the body's ability to fight infection develops.
In the online version of Nature Immunology, neurology professor Dr. Michael Demetriou, postdoctoral scholar Raymond Zhou and other Institute for Immunology colleagues describe a critical mechanism underlying how T cells are created, selected and released into the bloodstream.
A T cell is a type of blood cell called a lymphocyte that protects ...
Expect 6,000 more Australian deaths if pollution rises to 'safe' threshold
2014-09-30
The National Environment Protection Measures (NEPM) has set maximum daily limits, or 'standards', for six key outdoor pollutants, which QUT's Associate Professor Adrian Barnett says many authorities wrongly assume to be 'safe' thresholds for health.
To test that assumption, Professor Barnett calculated what the health effects would be if the current average levels of five of those pollutants across Melbourne, Sydney and Brisbane were to rise to just below the NEPM 'safe' standards.
"I've found that increasing pollution levels to just below the NEPM standards would cause ...
How to predict who will suffer the most from stress
2014-09-30
Montreal, September 30, 2014 — More than 23 per cent of Canadians report being stressed or very stressed on most days. While chronic stress increases the risk of poor mental and physical health, not everyone is affected the same way. Some cope well, but for others — especially those most likely to sweat the small stuff — chronic stress can be harmful.
Thankfully, new research from Concordia University has found a way to identify those most susceptible to stress. That's a huge help for healthcare professionals working to stop stress before it gets out of control.
The ...
Antioxidant found in grapes uncorks new targets for acne treatment
2014-09-30
Got grapes? UCLA researchers have demonstrated how resveratrol, an antioxidant derived from grapes and found in wine, works to inhibit growth of the bacteria that causes acne.
The team also found that combining resveratrol with a common acne medication, benzoyl peroxide, may enhance the drug's ability to kill the bacteria and could translate into new treatments.
Published in the current online edition of the journal Dermatology and Therapy, the early lab findings demonstrated that resveratrol and benzoyl peroxide attack the acne bacteria, called Propionibacterium acnes, ...
New hypothyroidism treatment guidelines from American Thyroid Association
2014-09-30
New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. New knowledge about thyroid physiology may help to explain these differences. An expert task force of the American Thyroid Association on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard of care is appropriate, and they present their recommendations in ...
High-speed drug screen
2014-09-30
CAMBRIDGE, MA -- MIT engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients.
In a study appearing in the journal Integrative Biology, the researchers used this technology to identify materials that can efficiently deliver RNA to zebrafish and also to rodents. This type of high-speed screen could help overcome one of the major bottlenecks in developing disease ...
US military making progress reducing stigma tied to seeking help for mental illness
2014-09-30
The U.S. Department of Defense has made progress in reducing the stigma associated with seeking help for mental illnesses such as depression and post-traumatic stress disorder, but more improvement is still needed, according to a new RAND Corporation study.
Despite efforts of both the Defense Department and the Veterans Health Administration to enhance mental health services, many service members still do not seek needed care for mental health problems. Defense officials have made a concerted effort to promote treatment as a way to reduce stigma, according to the study. ...